Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma
Non-drug Procedure for Asthma Highlighted at ATS 2009
SUNNYVALE, Calif., May 18 /PRNewswire/ -- Results of the Asthma Intervention Research 2 (AIR2) Trial of the Alair(R) Bronchial Thermoplasty System, developed by Asthmatx, Inc., were announced today at ATS 2009, the International Conferenc...
Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children
SAN FRANCISCO, March 5 /PRNewswire-USNewswire/ -- Atopic dermatitis, the common, chronic, inflammatory skin disease marked by red, itchy rashes, has been increasing in prevalence over the past two decades and affects a disproportionate number of children. According to current estimates, approximat...
New Analysis Estimates Numbers of Older U.S. Adults Who May Benefit From Statin Therapy
American Heart Association rapid access journal report:
A new analysis estimates more than 11 million older Americans could be newly eligible for statin therapy if findings from the JUPITER trial are adopted into guidelines.
That could take the...
Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy
SEATTLE, Dec. 6 /PRNewswire-FirstCall/ -- Results from RESTORE 2, a
placebo-controlled, Phase III study demonstrated that the investigational
compound retigabine significantly reduced the number of seizures in adult
patients with refractory partial-onset epilepsy when a 600 mg or 900 mg dose
Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome
- Results Presented at ASH Annual Meeting-
SAN FRANCISCO, Dec. 6 /PRNewswire-FirstCall/ -- Sanofi-aventis today announced results of a randomized phase III study presented at the 50th Annual Meeting of the American Society of Hematology. The study in adult patients with hematological mali...
Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD
Data also found SYMBICORT opened airways in less than 15 minutes
WILMINGTON, Del., Oct. 29 /PRNewswire-FirstCall/ -- Data presented
today from two pivotal efficacy and safety trials, SHINE and SUN,
demonstrated that SYMBICORT(R) (budesonide/formoterol fumarate dihydrate)
Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
In a clinical study of adults, VYVANSE taken once-daily significantly
improved the symptoms of ADHD within one week
PHILADELPHIA, Oct. 7 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP,
Nasdaq: SHPGY), the global specialty biopharmaceutical company, today
announced that a study published in th...
Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma
WILMINGTON, Del., Sept. 10 /PRNewswire-FirstCall/ -- Newly released
results from two previously published studies demonstrated patients
receiving the maintenance combination asthma therapy SYMBICORT(R)
(budesonide/formoterol fumarate dihydrate) Inhalation Aerosol achieved
bronchodilation, or o...
Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
- Once-daily TMC278, the third anti-HIV compound to be developed in Tibotec virology portfolio -
YARDLEY, Pa., July 17 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd.
announced today that two major phase III efficacy trials examining TMC278,
its investigational non-nucleosi...
Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
Submitted to FDA for Stand-Alone Therapy in Q1 2008
SAN FRANCISCO, June 7 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. (Nasdaq: AMLN ) and Eli Lilly and Company (NYSE: LLY ) today announced
additional results from a study of patients with type 2 diabetes who were
Naturally Occurring Compounds in Cocoa Tied to Blood Flow Improvements for Adults With Type 2 Diabetes
Breakthrough study links cocoa flavanols to positive impact on diabetes-related blood vessel dysfunction
MCLEAN, Va., May 27 /PRNewswire/ -- Scientists have found that
consuming cocoa flavanols -- naturally occurring compounds in cocoa -- may
offer a benefit to those affecte...
Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
VYVANSE demonstrated significant improvement in ADHD symptoms in adults
WASHINGTON, May 8 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP,
Nasdaq: SHPGY), the global specialty biopharmaceutical company, today
presented the results of a phase III pivotal study in which VYVANSE
Study Compares Bronchodilatory Effects of SYMBICORT(R) and Advair in Adults With Asthma
Data Showed Faster Onset with SYMBICORT with Improved Lung Function within 3 and 15 Minutes
WILMINGTON, Del., March 18 /PRNewswire-FirstCall/ -- Data from a new
study demonstrated that the combination asthma maintenance therapy,
SYMBICORT(R) (budesonide/formoterol fum...
New Data Show Unacceptably Low Adult Immunization Rates and That Adults Unaware of Infectious Disease Threat
Experts Urge Integration of Adult Vaccines into Routine Care to Save Lives, Reduce Needless Illness
WASHINGTON, Jan. 23 /PRNewswire-USNewswire/ -- New data released today
by the Centers for Disease Control and Prevention (CDC) paint a
disappointing picture of adult immuniz...
Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
First and only medication approved to reduce both A1C and LDL cholesterol
PARSIPPANY, N.J., Jan. 22 /PRNewswire/ -- Daiichi Sankyo, Inc.,
announced that the United States Food and Drug Administration (FDA) has
approved Welchol(TM) (colesevelam HCl) to improve glycemic control
(measured as hemog...
Children's Hospital Cancer Study Finds Adolescents and Young Adults Don't Get Same Access to Cutting-Edge Treatment as Younger Patients
PITTSBURGH, Jan. 15 /PRNewswire/ -- The overall survival rate from
cancer now is lower in older adolescents and young adults
with cancer than
in younger children, in part because of a lack of access to clinical trials
nationally for the older age group, according to a study by pediatric
European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
- Product Developed Through Joint Venture Between Bristol-Myers Squibb and Gilead Sciences, the First of Its Kind in HIV Treatment -
PRINCETON, N.J. and FOSTER CITY, Calif., Dec. 17 /PRNewswire-FirstCall/
-- The European Commission has granted marketing authorization for
Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
- Data presented at American College of Rheumatology Annual Congress -
BOSTON, Nov. 12 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company
(NYSE: BMY ) today announced the results of three post-hoc analyses from two
Phase III pivotal trials that showed ORENCIA(R) (abatacept) improved dail...
Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
- Data Presented at American College of Rheumatology Annual Meeting -
BOSTON, Nov. 9 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company
(NYSE: BMY ) today announced that cumulative five-year data from an
open-label long-term extension of a Phase IIb trial demonstrate the
Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
DALLAS, Nov. 1 /PRNewswire-USNewswire/ -- Death resulting from
influenza, often referred to as "the flu," is more common among individuals
with heart disease than among patients with any other chronic medical
condition. However, according to a new nationwide survey of heart disease
Younger Adults Increasingly Treated for Heart Disease-related Conditions
Increase in use of cholesterol and hypertension medications largest among people ages 20 to 44
Drop in the age of women using heart disease medications greater than men
FRANKLIN LAKES, N.J., Oct. 30 /PRNewswire-FirstCall/ -- Heart disease,
high blood pressure and harde...
New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
Interim Results From Open-Label Follow-up Include Longer-term Safety Findings
BOSTON, Oct. 26 /PRNewswire/ -- Adults
with Attention Deficit
Hyperactivity Disorder (ADHD) treated with CONCERTA(R) OROS(R)
methylphenidate HCl Extended-release Tablets showed signif...
New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
- PREZISTA/ritonavir data presented at ICAAC -
BRIDGEWATER, N.J., Sept. 18 /PRNewswire/ -- Results from a new ongoing,
randomized, controlled, open-label Phase 3 study showed that 84 percent of
treatment-naive HIV-1 infected adults
taking an investigational dose of
New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
CAIRNS, Australia, Aug. 31 /PRNewswire/ -- What and When Data from a six-month study of ramelteon will be presented in poster
format at worldsleep07: The 5th World Congress of the World Federation of
Sleep Research and Sleep Medicine Societies to be held in Cairns, Australia
September 2-6, 2...
Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
- New antiepileptic drug with novel mechanism of action helps address critical unmet medical need for many people living with uncontrolled epilepsy
- Vimpat(R) offers hope to people with epilepsy who still have uncontrolled partial onset seizures with current treatment
ATLANTA, May 26 ...
Heavy Marijuana Use May Damage Developing Brain in Teens, Young Adults
PHILADELPHIA, Feb. 2 /PRNewswire-USNewswire/ -- Adolescents and young adults
who are heavy users of marijuana are more likely than non-users to have disrupted brain development, according to a new study. Pediatric researchers found abnormalities in areas of the brain that interconnect brain region...
Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults
ANN ARBOR, Mich., Jan. 16 /PRNewswire/ -- Use of prescription sleep aids
nearly tripled among 18- to 24-year-olds between 1998 and 2006, according to a
study released today by the Healthcare business of Thomson Reuters.
During the study period, the average length of time sleep aids were...
FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults
INDIANAPOLIS, Jan. 7 /PRNewswire-FirstCall/ -- Eli Lilly and Company
(NYSE: LLY ) announced today that it received a complete response letter from
the U.S. Food and Drug Administration (FDA) for olanzapine long-acting
injection (LAI) for acute and maintenance treatment of schizophrenia in
Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults
Synvista Therapeutics Technology Provided CML Biomarker Data for Studies
MONTVALE, N.J., Dec. 16 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. ( NYSE Alternext US: SYI ) today announced two publications demonstrating findings from studies that indicated that the presence of th...
Exercise Helps Prevent Age-Related Brain Changes in Older Adults
CHICAGO, Dec. 1 /PRNewswire-USNewswire/ -- Older adults
who exercise regularly show increased cerebral blood flow and a greater number of small blood vessels in the brain, according to findings presented today at the annual meeting of the Radiological Society of North America (RSNA).
New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults
SAN FRANCISCO, Nov. 19 /PRNewswire/ -- Posit Science Corporation
researcher, Dan Tinker, presented evidence at the Society for Neuroscience
Annual Conference in Washington, DC this week indicating that cognitive
training may benefit Baby Boomers. The computerized brain plasticity-based
Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults
- Ninety-six week ARTEMIS data presented at ICAAC -
BRIDGEWATER, N.J., Oct. 26 /PRNewswire/ -- Ninety-six week results
presented today from a phase 3, randomized, open-label, ongoing clinical
trial showed that 79 percent of treatment-naive HIV-1 infected adults
taking PREZISTA(R) 800 mg (t...
Study Shows Benefits of a High Omega-3 Diet in Older Adults
High Omega-3 Fat Intake Improves Insulin Sensitivity and Reduces
Inflammatory Markers, But Does Not Alter Endocrine Responsiveness
PHOENIX, Aug. 13 /PRNewswire-USNewswire/ -- A study conducted by
Phoenix-based Kronos Longevity Research Institute (KLRI) found that a diet
high in omega-3 fat i...
New Clinical Data Further Supports Chromium Picolinate's Role in Enhancing Brain Activity in Older Adults
Study Used Key Ingredient in Core4Life Advanced Memory Formula(TM)
PURCHASE, N.Y., March 4 /PRNewswire-FirstCall/ -- Nutrition 21, Inc.
(Nasdaq: NXXI ), a developer and marketer of nutritional supplements that
help consumers manage blood sugar levels, improve cardiovascular health,
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
Amoxicillin PULSYS to be Marketed as MOXATAG(TM) - First Once-Daily Amoxicillin Product Approved in U.S.
GERMANTOWN, Md., Jan. 24 /PRNewswire-FirstCall/ -- MiddleBrook
Pharmaceuticals, Inc. (Nasdaq: MBRK ), a pharmaceutical company focused on
developing and commercializing ...
Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Company Plans to File Supplemental New Drug Application with FDA in First Quarter 2008
SOUTH SAN FRANCISCO, Calif., Oct. 16 /PRNewswire-FirstCall/ -- Anesiva,
Inc. (Nasdaq: ANSV ) today announced positive top-line results from its
pivotal Phase 3 trial. The multi-c...
Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
Completion of Adult Trial Enrollment follows FDA approval of Zingo in Children
SOUTH SAN FRANCISCO, Calif., Aug. 28 /PRNewswire-FirstCall/ -- Anesiva,
Inc. (Nasdaq: ANSV ) announced today that it has completed enrollment of the
Phase 3 clinical study of Zingo(T...
Eighty-one Percent of U.S. Adults say that Birth Control Pills and
Procedures Should Be Covered by Health Insurance
Support for Medical Use Approval and Insurance Coverage Varies
Greatly for Different Medical Treatments
ROCHESTER, N.Y. - April 30, 2007-- Most U.S. adults
approving the use of medical treatments and procedures that can
impact people's quality of life, including birth control
New Study Demonstrates that Lubiprostone May Improve Symptom Relief
Rates in Adults with Irritable Bowel Syndrome with Constipation
WASHINGTON, May 21, 2007 /PRNewswire/ -- A new study
demonstrated that the active ingredient in Amitiza (lubiprostone),
given 8 mcg twice a day, may improve symptom relief rates in adults
with irritable bowel syndrome with constipation (IBS-C). These
results were presented as a late-breaker at Dig...
FDA Proposes New Warnings About Suicidal Thinking, Behavior in
Young Adults Who Take Antidepressant Medications
ROCKVILLE, Md., May 2, 2007-The U.S. Food and Drug
Administration (FDA) today proposed that makers of all
antidepressant medications update the existing black box warning on
their products' labeling to include warnings about increased risks
of suicidal thinking and behavior, known as suicidality, ...